Search Results - "Patel, Priti"

Forced sterilization of women as discrimination by Patel, Priti

“…There has been a long history of subjecting marginalized women to forced and coerced sterilization. In recent years, the practice has been documented in…”
Get full text

Opportunities for Enhanced Prevention and Control of Hepatitis C Through Improved Screening and Testing Efforts by Cartwright, Emily J, Patel, Priti R

“…An estimated 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. In 2020, the Centers for Disease Control and Prevention…”
Get full text

Emergency Department Visits for Antibiotic-Associated Adverse Events by Shehab, Nadine, Patel, Priti R., Srinivasan, Arjun, Budnitz, Daniel S.

“…Background.Drug-related adverse events are an underappreciated consequence of antibiotic use, and the national magnitude and scope of these events have not…”
Get full text

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial by Byrd, John C, Hillmen, Peter, Ghia, Paolo, Kater, Arnon P, Chanan-Khan, Asher, Furman, Richard R, O'Brien, Susan, Yenerel, Mustafa Nuri, Illés, Arpad, Kay, Neil, Garcia-Marco, Jose A, Mato, Anthony, Pinilla-Ibarz, Javier, Seymour, John F, Lepretre, Stephane, Stilgenbauer, Stephan, Robak, Tadeusz, Rothbaum, Wayne, Izumi, Raquel, Hamdy, Ahmed, Patel, Priti, Higgins, Kara, Sohoni, Sophia, Jurczak, Wojciech

“…Among Bruton's tyrosine kinase inhibitors, acalabrutinib has greater selectivity than ibrutinib, which we hypothesized would improve continuous therapy…”
Get full text

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia by Ghia, Paolo, Pluta, Andrzej, Wach, Malgorzata, Lysak, Daniel, Kozak, Tomas, Simkovic, Martin, Kaplan, Polina, Kraychok, Iryna, Illes, Arpad, de la Serna, Javier, Dolan, Sean, Campbell, Phillip, Musuraca, Gerardo, Jacob, Abraham, Avery, Eric, Lee, Jae Hoon, Liang, Wei, Patel, Priti, Quah, Cheng, Jurczak, Wojciech

“…Acalabrutinib, a highly selective, potent, Bruton tyrosine kinase inhibitor, was evaluated in this global, multicenter, randomized, open-label, phase III study…”
Get full text

The Making Dialysis Safer for Patients Coalition: A New Partnership to Prevent Hemodialysis-Related Infections by Patel, Priti R, Brinsley-Rainisch, Kristin

“…The is a partnership of organizations and individual stakeholders that share the common goal to prevent bloodstream infections among patients receiving…”
Get full text

National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014 by Nguyen, Duc B, Shugart, Alicia, Lines, Christi, Shah, Ami B, Edwards, Jonathan, Pollock, Daniel, Sievert, Dawn, Patel, Priti R

“…Persons receiving outpatient hemodialysis are at risk for bloodstream and vascular access infections. The Centers for Disease Control and Prevention conducts…”
Get full text

The Role of U.S. Public Health Agencies in Addressing Long COVID by Patel, Priti R., Desai, Jay R., Plescia, Marcus, Baggett, Jessica, Briss, Peter

Get full text

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial by Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D, Damaj, Gandhi, Doorduijn, Jeanette, Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal, Davies, Andrew, Eek, Richard, Dupuis, Jehan, Jacobsen, Eric, Kater, Arnon P, Le Gouill, Steven, Oberic, Lucie, Robak, Taduesz, Covey, Todd, Dua, Richa, Hamdy, Ahmed, Huang, Xin, Izumi, Raquel, Patel, Priti, Rothbaum, Wayne, Slatter, J Greg, Jurczak, Wojciech

“…Bruton tyrosine kinase is a clinically validated target in mantle cell lymphoma. Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine kinase…”
Get full text

Risk of Vascular Access Infection Associated With Buttonhole Cannulation of Fistulas: Data From the National Healthcare Safety Network by Lyman, Meghan, Nguyen, Duc B., Shugart, Alicia, Gruhler, Heidi, Lines, Christi, Patel, Priti R.

“…Compared with conventional (rope-ladder cannulation [RLC]) methods, use of buttonhole cannulation (BHC) to access arteriovenous fistulas (AVFs) may be…”
Get full text

Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention by Nguyen, Duc B., Bixler, Danae, Patel, Priti R.

“…Hepatitis C virus (HCV) infection is more common among hemodialysis patients than the general population and transmission of HCV in dialysis clinics has been…”
Get full text

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management by Jadoul, Michel, Berenguer, Marina C, Doss, Wahid, Fabrizi, Fabrizio, Izopet, Jacques, Jha, Vivekanand, Kamar, Nassim, Kasiske, Bertram L, Lai, Ching-Lung, Morales, José M, Patel, Priti R, Pol, Stanislas, Silva, Marcelo O, Balk, Ethan M, Gordon, Craig E, Earley, Amy, Di, Mengyang, Martin, Paul

“…Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including…”
Get more information

Preventing Catheter-Related Bloodstream Infections outside the Intensive Care Unit: Expanding Prevention to New Settings by Kallen, Alexander J., Patel, Priti R., O'Grady, Naomi P., Weinstein, Robert A.

“…With the growing recognition of the preventability of catheter-related bloodstream infections (CRBSIs), reducing the number of CRBSIs acquired in health care…”
Get full text

Can intravenous antimicrobial start data reported to the National Healthcare Safety Network determine appropriateness of antibiotic use in hemodialysis patients? by Patel, Priti R., Novosad, Shannon A., Apata, Ibironke W.

“…The authors examined outpatient IV antimicrobial start (IVAS) events reported to NHSN and considered any IVAS without documentation of coreported positive…”
Get full text

Bloodstream Infection Rates in Outpatient Hemodialysis Facilities Participating in a Collaborative Prevention Effort: A Quality Improvement Report by Patel, Priti R., MD, MPH, Yi, Sarah H., PhD, Booth, Stephanie, CCHT, Bren, Virginia, MPH, RN, CIC, Downham, Gemma, MPH, CIC, Hess, Sally, CIC, MPH, Kelley, Karen, RN, BSN, CNN, Lincoln, Mary, BSN, MHA, Morrissette, Kathy, RN, RVT, Lindberg, Curt, DMan, Jernigan, John A., MD, MS, Kallen, Alexander J., MD, MPH

“…Background Bloodstream infections (BSIs) cause substantial morbidity in hemodialysis patients. In 2009, the US Centers for Disease Control and Prevention (CDC)…”
Get full text

Human Factors Contributing to Infection Prevention in Outpatient Hemodialysis Centers: A Mixed Methods Study by Parker, Sarah Henrickson, Jesso, Matthew N., Wolf, Laurie D., Leigh, Kerry Avondet, Booth, Stephanie, Gualandi, Nicole, Garrick, Renee E., Kliger, Alan S., Patel, Priti R.

“…Infection prevention efforts in dialysis centers can avert patient morbidity and mortality but are challenging to implement. The objective of this study was to…”
Get full text

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia by Rogers, Kerry A., Thompson, Philip A., Allan, John N., Coleman, Morton, Sharman, Jeff P., Cheson, Bruce D., Jones, Daniel, Izumi, Raquel, Frigault, Melanie M., Quah, Cheng, Raman, Rakesh K., Patel, Priti, Wang, Min Hui, Kipps, Thomas J.

“…B-cell receptor signalling inhibition by targeting Bruton tyrosine kinase (BTK) is effective in treating chronic lymphocytic leukemia (CLL). The BTK inhibitor…”
Get full text

In Reply to ‘Bloodstream Infections in Hemodialysis Patients: The Role of Dialysis Providers’ by Novosad, Shannon A., Patel, Priti R.

Get full text

Health Care–Associated Invasive MRSA Infections, 2005-2008 by Kallen, Alexander J, Mu, Yi, Bulens, Sandra, Reingold, Arthur, Petit, Susan, Gershman, Ken, Ray, Susan M, Harrison, Lee H, Lynfield, Ruth, Dumyati, Ghinwa, Townes, John M, Schaffner, William, Patel, Priti R, Fridkin, Scott K, Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program, for the

“…CONTEXT Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance; MRSA prevention programs that may affect MRSA…”
Get full text

Assessment of Provision of COVID-19 Vaccination in Dialysis Clinics and Patient Vaccination Coverage by Patel, Priti R, Tanz, Lauren J, Hamilton, Emel, Swanzy, Katie, Hymes, Jeffrey L, Giullian, Jeff, Novosad, Shannon A

Get more information